Olema Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Olema Pharmaceuticals Stock Summary

Olema Pharmaceuticals competes with RenovoRx, Scpharmaceuticals, and Milestone Pharmaceuticals. Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for womens cancers. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. Olema Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people.

Olema Pharmaceuticals Key Financial Ratios

Olema Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Olema Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Olema Pharmaceuticals over time and compare it to other companies across industries.

Olema Pharmaceuticals Key Balance Sheet Accounts

Olema Pharmaceuticals Key Income Statement Accounts

Olema Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Olema Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Olema Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Olema Pharmaceuticals competition to find correlations between indicators driving Olema Pharmaceuticals's intrinsic value. More Info.Olema Pharmaceuticals is considered to be number one stock in return on equity category among its peers. It is regarded second in return on asset category among its peers . At present, Olema Pharmaceuticals' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Olema Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Olema Pharmaceuticals Systematic Risk

Today, most investors in Olema Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Olema Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Olema Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Olema Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Olema Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Olema Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Olema Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Olema Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.